A trial of Human Cytomegalovirus Immunoglobulin (pH4).

Trial Profile

A trial of Human Cytomegalovirus Immunoglobulin (pH4).

Phase of Trial: Phase I

Latest Information Update: 02 Mar 2017

At a glance

  • Drugs Cytomegalovirus immune globulin (Primary)
  • Indications Cytomegalovirus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Mar 2017 New trial record
    • 23 Feb 2017 According to a China Biologic media release, company received CFDA approvals to commence this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top